Expression of MIP-1α (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells

Journal of Virology

Volumn 84, Issue 18, 2010, Pages 9642-9648

  Zhao, Ling ^a   Toriumi, Harufusa ^a,d   Wang, Hualei ^a,b   Kuang, Yi ^a   Guo, Xiaofeng ^a,e   Morimoto, Kinjiro ^c   Fu, Zhen F ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b JILIN UNIVERSITY   (China)

^c YASUDA WOMEN'S UNIVERSITY   (Japan)

^d RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^e SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; RANTES; VIRUS ANTIBODY; VIRUS RNA; CCL3 PROTEIN, MOUSE; RABIES VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MEGADOSE; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INNATE IMMUNITY; INOCULATION; LOW DRUG DOSE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; VIRAL GENE THERAPY; VIRUS RECOMBINANT; VIRUS VIRULENCE; ANIMAL; BIOSYNTHESIS; BLOOD; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; VIROLOGY;

MUS; RABIES VIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CHEMOKINE CCL3; DENDRITIC CELLS; IMMUNITY, INNATE; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; RABIES VACCINES; RABIES VIRUS;

EID: 77956019365     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00326-10     Document Type: Article

References (35)

1. Barouch, D. H., P. F. McKay, S. M. Sumida, S. Santra, S. S. Jackson, D. A. Gorgone, M. A. Lifton, B. K. Chakrabarti, L. Xu, G. J. Nabel, and N. L. Letvin. 2003. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J. Virol. 77:8729-8735.
2. Castigli, E., F. Young, A. M. Carossino, F. W. Alt, and R. S. Geha. 1996. CD40 expression and function in murine B cell ontogeny. Int. Immunol. 8:405-411.
3. Centers for Disease Control and Prevention. 2009. Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009. MMWR Morb. Mortal. Wkly. Rep. 58:1204-1207.
4. Clark, E. A. 1997. Regulation of B lymphocytes by dendritic cells. J. Exp. Med. 185:801-803.
5. Corcione, A., G. Tortolina, R. Bonecchi, N. Battilana, G. Taborelli, F. Malavasi, S. Sozzani, L. Ottonello, F. Dallegri, and V. Pistoia. 2002. Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. Int. Immunol. 14:883-892.
6. Dietzschold, B., M. Kao, Y. M. Zheng, Z. Y. Chen, G. Maul, Z. F. Fu, C. E. Rupprecht, and H. Koprowski. 1992. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 89:7252-7256.
7. Dubois, B., J. M. Bridon, J. Fayette, C. Barthelemy, J. Banchereau, C. Caux, and F. Briere. 1999. Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol. 66:224-230.
8. Fu, Z. F. 1997. Rabies and rabies research: past, present and future. Vaccine 15(Suppl.):S20-S24. (Pubitemid 27278175)
9. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82.
10. Hanlon, C. A., M. Niezgoda, A. N. Hamir, C. Schumacher, H. Koprowski, and C. E. Rupprecht. 1998. First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J. Wildl. Dis. 34:228-239.
11. Hanlon, C. A., M. Niezgoda, P. Morrill, and C. E. Rupprecht. 2002. Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons. J. Wildl. Dis. 38:420-427.
12. Hooper, D. C., K. Morimoto, M. Bette, E. Weihe, H. Koprowski, and B. Dietzschold. 1998. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 72:3711-3719.
13. Inoue, K., Y. Shoji, I. Kurane, T. Iijima, T. Sakai, and K. Morimoto. 2003. An improved method for recovering rabies virus from cloned cDNA. J. Virol. Methods 107:229-236.
14. Johnson, N., C. S. McKimmie, K. L. Mansfield, P. R. Wakeley, S. M. Brookes, J. K. Fazakerley, and A. R. Fooks. 2006. Lyssavirus infection activates interferon gene expression in the brain. J. Gen. Virol. 87:2663-2667.
15. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the Cd19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-2672.
16. Kuang, Y., S. N. Lackay, L. Zhao, and Z. F. Fu. 2009. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res. 144:18-26.
17. Kurts, C. 2008. CD11c: not merely a murine DC marker, but also a useful vaccination target. Eur. J. Immunol. 38:2072-2075.
18. Li, J. W., J. P. McGettigan, M. Faber, M. J. Schnell, and B. Dietzschold. 2008. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NF kappa B signaling pathway. Vaccine 26:419-426.
19. Maurer, M., and E. von Stebut. 2004. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36:1882-1886.
20. McKay, P. F., D. H. Barouch, S. Santra, S. M. Sumida, S. S. Jackson, D. A. Gorgone, M. A. Lifton, and N. L. Letvin. 2004. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4(+) and CD8(+) T lymphocyte responses. Eur. J. Immunol. 34:1011-1020.
21. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
22. Nakamichi, K., S. Inoue, T. Takasaki, K. Morimoto, and I. Kurane. 2004. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J. Virol. 78:9376-9388.
23. Préhaud, C., F. Megret, M. Lafage, and M. Lafon. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79:12893-12904. (Pubitemid 41433208)
24. Rupprecht, C. E., D. Briggs, C. M. Brown, R. Franka, S. L. Katz, H. D. Kerr, S. M. Lett, R. Levis, M. I. Meltzer, W. Schaffner, and P. R. Cieslak. 2010. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recommend. Rep. 59(RR-2):1-9.
25. Rupprecht, C. E., L. Blass, K. Smith, L. A. Orciari, M. Niezgoda, S. G. Whitfield, R. V. Gibbons, M. Guerra, and C. A. Hanlon. 2001. Human infection due to recombinant vaccinia-rabies glycoprotein virus. N. Engl. J. Med. 345:582-586.
26. Schall, T. J., K. Bacon, R. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821-1826.
27. Smith, J. S., P. A. Yager, and G. M. Baer. 1996. A rapid fluorescence focus inhibition test (RFFIT) for determining rabies virus-neutralisng antibody, p. 181-192. In F.-X. Meslin, M. M. Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, Switzerland.
28. Trabelsi, K., S. Rourou, H. Loukil, S. Majoul, and H. Kallel. 2006. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J. Biotechnol. 121:261-271.
29. Wandeler, A. I., S. Capt, A. Kappeler, and R. Hauser. 1988. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 10(Suppl. 4):S649-S653.
30. Wang, Z. W., L. Sarmento, Y. Wang, X. Q. Li, V. Dhingra, T. Tseggai, B. Jiang, and Z. F. Fu. 2005. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 79:12554-12565.
31. World Health Organization. 2005. WHO expert consultation on rabies: first report, p. 1-121. WHO technical report series; 931. World Health Organization, Geneva, Switzerland.
32. Wykes, M., and G. MacPherson. 2000. Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 100:1-3. (Pubitemid 30242875)
33. Wykes, M., A. Pombo, C. Jenkins, and G. G. MacPherson. 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161:1313-1319.
34. Yong, M., D. Mitchell, A. Caudron, I. Toth, and C. Olive. 2009. Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. Vaccine 27:3313-3318.
35. Zhao, L., H. Toriumi, Y. Kuang, H. Chen, and Z. F. Fu. 2009. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J. Virol. 83:11808-11818.